[
  {
    "ts": "2025-11-21T13:15:00+00:00",
    "headline": "Top 2 Healthcare Stocks Every New Investor Should Know",
    "summary": "These healthcare stocks have long-term and profitable growth runways.",
    "url": "https://www.fool.com/investing/2025/11/21/top-2-healthcare-stocks-new-investors-should-know/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "4617c638-7aed-3192-944e-beac629b0cfb",
      "content": {
        "id": "4617c638-7aed-3192-944e-beac629b0cfb",
        "contentType": "STORY",
        "title": "Top 2 Healthcare Stocks Every New Investor Should Know",
        "description": "",
        "summary": "These healthcare stocks have long-term and profitable growth runways.",
        "pubDate": "2025-11-21T13:15:00Z",
        "displayTime": "2025-11-21T13:15:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/273870ebff2cb8a98ba70ea9f84ede3f",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "Investor reviewing figures on tablet while standing opposite a building displaying stock numbers.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pu.1PkaXCUeQzSrngDgZWw--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/273870ebff2cb8a98ba70ea9f84ede3f.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/s78skoW6YYC5guFyBoG74g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/273870ebff2cb8a98ba70ea9f84ede3f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/21/top-2-healthcare-stocks-new-investors-should-know/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/top-2-healthcare-stocks-every-131500752.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DXCM"
            },
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-21T23:51:00+00:00",
    "headline": "AbbVie, Biogen, BioMarin Pharmaceutical, DexCom, and Abbott Laboratories Stocks Trade Up, What You Need To Know",
    "summary": "A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated he sees “room for a further adjustment” in the near term, sparking a significant market rally. Following his remarks, the probability of the central bank cutting rates at its December meeting jumped from 39% to over 73%, according to the CME FedWatch tool. This positive sentiment provided relief to",
    "url": "https://finance.yahoo.com/news/abbvie-biogen-biomarin-pharmaceutical-dexcom-235100264.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "15929d4c-b37e-3fd3-bc4e-8ad4ace5531e",
      "content": {
        "id": "15929d4c-b37e-3fd3-bc4e-8ad4ace5531e",
        "contentType": "STORY",
        "title": "AbbVie, Biogen, BioMarin Pharmaceutical, DexCom, and Abbott Laboratories Stocks Trade Up, What You Need To Know",
        "description": "",
        "summary": "A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated he sees “room for a further adjustment” in the near term, sparking a significant market rally. Following his remarks, the probability of the central bank cutting rates at its December meeting jumped from 39% to over 73%, according to the CME FedWatch tool. This positive sentiment provided relief to",
        "pubDate": "2025-11-21T23:51:00Z",
        "displayTime": "2025-11-21T23:51:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/621a415265c388bc8e9eb8ecaf0fb0a8",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "ABBV Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/K222hrzb0FJJlqrDZzsz7w--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/621a415265c388bc8e9eb8ecaf0fb0a8.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cD3IChyAhZhexmnMXW7jMA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/621a415265c388bc8e9eb8ecaf0fb0a8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-biogen-biomarin-pharmaceutical-dexcom-235100264.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-biogen-biomarin-pharmaceutical-dexcom-235100264.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "BIIB"
            },
            {
              "symbol": "BMRN"
            },
            {
              "symbol": "DXCM"
            },
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]